Noninvasive pulsed focused ultrasound allows spatiotemporal control of targeted homing for multiple stem cell types in murine skeletal muscle and the magnitude of cell homing can be increased through repeated applications

Stem Cells

Volumn 31, Issue 11, 2013, Pages 2551-2560

  Burks, Scott R ^a,b   Ziadloo, Ali ^a   Kim, Saejeong J ^a   Nguyen, Ben A ^a   Frank, Joseph A ^a,b  

^a CLINICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

Author keywords

Endothelial precursor cells; High intensity focused ultrasound; Mesenchymal stem cells; Pulsed focused ultrasound; Stem cells; Targeted delivery

Indexed keywords

CELL ADHESION MOLECULE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 9; MONOCYTE CHEMOTACTIC PROTEIN 1; STROMAL CELL DERIVED FACTOR 1ALPHA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; CARDIOVASCULAR DISEASE; CELL HOMING; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; ECHOGRAPHY; ENDOTHELIAL PROGENITOR CELL; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; MESENCHYMAL STEM CELL; MOUSE; MUSCLE TISSUE; NONHUMAN; PULSED FOCUSED ULTRASOUND; SKELETAL MUSCLE; TARGET CELL; TROPISM; ULTRASOUND THERAPY; UPREGULATION;

MURINAE;

ENDOTHELIAL PRECURSOR CELLS; HIGH INTENSITY FOCUSED ULTRASOUND; MESENCHYMAL STEM CELLS; PULSED FOCUSED ULTRASOUND; STEM CELLS; TARGETED DELIVERY;

ANIMALS; CELL CULTURE TECHNIQUES; CYTOKINES; FEMALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C3H; MODELS, ANIMAL; MUSCLE, SKELETAL; SPATIO-TEMPORAL ANALYSIS; STEM CELLS; ULTRASONICS;

EID: 84887943083     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1495     Document Type: Article

References (49)

1. Schrepfer S, Deuse T, Reichenspurner H et al. Stem cell transplantation: The lung barrier. Transplant Proc 2007; 39: 573-576. (Pubitemid 46386222)
2. Detante O, Moisan A, Dimastromatteo J et al. Intravenous administration of 99mTc-HMPAO-labeled human mesenchymal stem cells after stroke: In vivo imaging and biodistribution. Cell Transplant 2009; 18: 1369-1379.
3. Ley K, Laudanna C, Cybulsky MI et al. Getting to the site of inflammation: The leukocyte adhesion cascade updated. Nat Rev Immunol 2007; 7: 678-689. (Pubitemid 47327397)
4. Karp JM, Leng Teo GS. Mesenchymal stem cell homing: The devil is in the details. Cell Stem Cell 2009; 4: 206-216.
5. Teo GS, Ankrum JA, Martinelli R et al. Mesenchymal stem cells transmigrate between and directly through tumor necrosis factor-alpha-activated endothelial cells via both leukocyte-like and novel mechanisms. Stem Cells 2012; 30: 2472-2486.
6. Borlongan CV, Glover LE, Tajiri N et al. The great migration of bone marrow-derived stem cells toward the ischemic brain: Therapeutic implications for stroke and other neurological disorders. Prog Neuro-biol 2011; 95: 213-228.
7. Nakashima H, Kaur B, Chiocca EA. Directing systemic oncolytic viral delivery to tumors via carrier cells. Cytokine Growth Factor Rev 2010; 21: 119-126.
8. Hilfiker A, Kasper C, Hass R et al. Mesenchymal stem cells and progenitor cells in connective tissue engineering and regenerative medicine: Is there a future for transplantation? Langenbecks Arch Surg 2011; 396: 489-497.
9. Chen J, Li Y, Wang L et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001; 32: 1005-1011. (Pubitemid 32285175)
10. Omori Y, Honmou O, Harada K et al. Optimization of a therapeutic protocol for intravenous injection of human mesenchymal stem cells after cerebral ischemia in adult rats. Brain Res 2008; 1236: 30-38.
11. Gul-Uludag H., Xu P, Marquez-Curtis LA et al. Cationic liposome-mediated CXCR4 gene delivery into hematopoietic stem/progenitor cells: Implications for clinical transplantation and gene therapy. Stem Cells Dev 2012; 21: 1587-1596.
12. Prowse AB, Chong F, Gray PP et al. Stem cell integrins: Implications for ex-vivo culture and cellular therapies. Stem Cell Res 2011; 6: 1-12.
13. Sarkar D, Spencer JA, Phillips JA et al. Engineered cell homing. Blood 2011; 118:e184-191.
14. Kang SK, Shin IS, Ko MS et al. Journey of mesenchymal stem cells for homing: Strategies to enhance efficacy and safety of stem cell therapy. Stem Cells Int 2012; 2012: 342968.
15. Arbab AS, Jordan EK, Wilson LB et al. In vivo trafficking and targeted delivery of magnetically labeled stem cells. CHum Gene Ther 2004; 15: 351-360. (Pubitemid 38469777)
16. Clement GT. Perspectives in clinical uses of high-intensity focused ultrasound. Ultrasonics 2004; 42: 1087-1093.
17. Tempany CM, McDannold NJ, Hynynen K et al. Focused ultrasound surgery in oncology: Overview and principles. Radiology 2011; 259: 39-56.
18. Kennedy JE. High-intensity focused ultrasound in the treatment of solid tumours. Nat Rev Cancer 2005; 5: 321-327. (Pubitemid 40488637)
19. Frenkel V. Ultrasound mediated delivery of drugs and genes to solid tumors. Adv Drug Deliv Rev 2008; 60: 1193-1208.
20. O'Reilly M.A., Hynynen K. Ultrasound enhanced drug delivery to the brain and central nervous system. Int J Hyperthermia 2012; 28: 386-396.
21. O'Neill B.E., Li KC. Augmentation of targeted delivery with pulsed high intensity focused ultrasound. Int J Hyperthermia 2008; 24: 506-520.
22. Burgess A, Ayala-Grosso CA, Ganguly M et al. Targeted delivery of neural stem cells to the brain using MRI-guided focused ultrasound to disrupt the blood-brain barrier. Plos One 2011; 6:e27877.
23. Chonpathompikunlert P, Fan CH, Ozaki Y et al. Redox nanoparticle treatment protects against neurological deficit in focused ultrasound-induced intracerebral hemorrhage. Nanomedicine (Lond) 2012; 7: 1029-1043.
24. Fan CH, Liu HL, Huang CY et al. Detection of intracerebral hemorrhage and transient blood-supply shortage in focused-ultrasound-induced blood-brain barrier disruption by ultrasound imaging. Ultrasound Med Biol 2012; 38: 1372-1382.
25. Hancock HA, Smith LH, Cuesta J et al. Investigations into pulsed high-intensity focused ultrasound-enhanced delivery: Preliminary evidence for a novel mechanism. Ultrasound Med Biol 2009; 35: 1722-1736.
26. Burks SR, Ziadloo A, Hancock HA et al. Investigation of cellular and molecular responses to pulsed focused ultrasound in a mouse model. Plos One 2011; 6:e24730.
27. Ziadloo A, Burks SR, Gold EM et al. Enhanced homing permeability and retention of bone marrow stromal cells by noninvasive pulsed focused ultrasound. Stem Cells 2012; 30: 1216-1227.
28. Alkins R, Burgess A, Ganguly M et al. Focused ultrasound delivers targeted immune cells to metastatic brain tumors. Cancer Res 2013; 73: 1892-1899.
29. Tang HL, Wang ZG, Li Q et al. Targeted delivery of bone mesenchy-mal stem cells by ultrasound destruction of microbubbles promotes kidney recovery in acute kidney injury. Ultrasound Med Biol 2012; 38: 661-669.
30. Zen K, Okigaki M, Hosokawa Y et al. Myocardium-targeted delivery of endothelial progenitor cells by ultrasound-mediated microbubble destruction improves cardiac function via an angiogenic response. J Mol Cell Cardiol 2006; 40: 799-809. (Pubitemid 43817039)
31. Ghanem A, Steingen C, Brenig F et al. Focused ultrasound-induced stimulation of microbubbles augments site-targeted engraftment of mesenchymal stem cells after acute myocardial infarction. J Mol Cell Cardiol 2009; 47: 411-418.
32. Zhong S, Shu S, Wang Z et al. Enhanced homing of mesenchymal stem cells to the ischemic myocardium by ultrasound-targeted micro-bubble destruction. Ultrasonics 2012; 52: 281-286.
33. Matsushita T, Kibayashi T, Katayama T et al. Mesenchymal stem cells transmigrate across brain microvascular endothelial cell monolayers through transiently formed inter-endothelial gaps. Neurosci Lett 2011; 502: 41-45.
34. Steingen C, Brenig F, Baumgartner L et al. Characterization of key mechanisms in transmigration and invasion of mesenchymal stem cells. J Mol Cell Cardiol 2008; 44: 1072-1084.
35. De Becker A., Van Hummelen P, Bakkus M et al. Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3. Haematologica 2007; 92: 440-449. (Pubitemid 350144289)
36. Walker DK, Fry CS, Drummond MJ et al. PAX71 satellite cells in young and older adults following resistance exercise. Muscle Nerve 2012; 46: 51-59.
37. Lepper C, Partridge TA, Fan CM. An absolute requirement for Pax7-positive satellite cells in acute injury-induced skeletal muscle regeneration. Development 2011; 138: 3639-3646.
38. McClellan JL, Davis JM, Steiner JL et al. Linking tumor-associated macrophages, inflammation, and intestinal tumorigenesis: Role of MCP-1. Am J Physiol Gastrointest Liver Physiol 2012; 303: G1087-G1095.
39. Miyata Y, Fukuhara A, Otsuki M et al. Expression of activating transcription factor 2 in inflammatory macrophages in obese adipose tissue. Obesity (Silver Spring). 2013; 21: 731-736.
40. Stauber WT, Clarkson PM, Fritz VK et al. Extracellular matrix disruption and pain after eccentric muscle action. J Appl Physiol 1990; 69: 868-874. (Pubitemid 20338683)
41. Gilfillan AM, Beaven MA. Regulation of mast cell responses in health and disease. Crit Rev Immunol 2011; 31: 475-529.
42. Baker BA, Rao KM, Mercer RR et al. Quantitative histology and MGF gene expression in rats following SSC exercise in vivo. Med Sci Sports Exerc 2006; 38: 463-471. (Pubitemid 43364121)
43. Martinez FO, Sica A, Mantovani A et al. Macrophage activation and polarization. Front Biosci 2008; 13: 453-461. (Pubitemid 351599757)
44. Yakeu G, Butcher L, Isa S et al. Low-intensity exercise enhances expression of markers of alternative activation in circulating leukocytes: Roles of PPARgamma and Th2 cytokines. Atherosclerosis 2010; 212: 668-673.
45. Bruun JM, Helge JW, Richelsen B et al. Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects. Am J Physiol Endocrinol Metab 2006; 290:E961-E967.
46. Cannon JG, St Pierre BA. Cytokines in exertion-induced skeletal muscle injury. Mol Cell Biochem 1998; 179: 159-167. (Pubitemid 28118850)
47. Lee RH, Pulin AA, Seo MJ et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009; 5: 54-63.
48. Huang J, Zhang Z, Guo J et al. Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium. Circ Res 2010; 106: 1753-1762.
49. Komatsu K, Honmou O, Suzuki J et al. Therapeutic time window of mesenchymal stem cells derived from bone marrow after cerebral ischemia. Brain Res 2010; 1334: 84-92.